As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

Welcome, ladies and gentlemen, to AstraZeneca's Investor Conference ... but I think we have the commercial execution in place to be able to bring along this change as well. So, as Professor ...

ADAURA Trail Results Reveal 79% Reduction in Risk of Death with Tagrisso The eagerly anticipated data from the Phase III ...

HALIX B.V., a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of ...

Morgane Delledonne, head of investment strategy at Global X ETFs, discusses how the Federal Reserve's interest rate policy and economic data impacts markets.

Positive results from the NIAGARA Phase III trial showed that UK pharma major AstraZeneca’s (LSE: AZN) Imfinzi (durvalumab) ...

Things To Check When Your Cat's Not Eating ...

JMP Securities has initiated coverage on BeiGene highlighting the Chinese biotech company as a 'unique investment opportunity.' The firm's leading drug, Brukinsa (zanubrutinib), is emerging in the ...

AstraZeneca has reported the first clinical ... All three of the injectables haven’t met commercial expectations, however, likely at least in part because their dosing route breaks with the ...